Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft. [electronic resource]
Producer: 20080304Description: 2567-74 p. digitalISSN:- 1460-2180
- Animals
- Anticarcinogenic Agents -- administration & dosage
- Cell Proliferation -- drug effects
- Cyclin-Dependent Kinase Inhibitor p21 -- metabolism
- Cyclin-Dependent Kinase Inhibitor p27 -- metabolism
- Diet
- Extracellular Signal-Regulated MAP Kinases -- metabolism
- Gene Expression Regulation, Neoplastic
- Humans
- Inhibitor of Apoptosis Proteins
- Insulin-Like Growth Factor Binding Protein 3 -- metabolism
- Male
- Mice
- Mice, Nude
- Microtubule-Associated Proteins -- metabolism
- Neoplasm Proteins -- metabolism
- Neoplasm Transplantation
- Prostatic Neoplasms -- metabolism
- Proto-Oncogene Proteins c-bcl-2 -- metabolism
- Silybin
- Silymarin -- administration & dosage
- Survivin
- Transplantation, Heterologous
- Vascular Endothelial Growth Factor A -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.